title: Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration.
abstract: BACKGROUND
  Uterocutaneous fistula is a rare complication of uterine surgery. All published cases have been surgically treated with hysterectomy and excision of the fistulous tract. We report a case of uterocutaneous fistula that was successfully treated with gonadotropin-releasing hormone agonist administration.
  
  
  METHODS
  A 25-year-old woman reported bloody discharge during her periods from a previous Pfannenstiel incision. A fistulous tract leading from the incision scar to the uterus was diagnosed. Leuprolide acetate depot was administered twice subcutaneously at a dose of 11.25 mg. The fistulous tract closed spontaneously, and the patient was symptom free thereafter.
  
  
  CONCLUSIONS
  Medical treatment with gonadotropin-releasing hormone agonists should be considered before resorting to surgery for treatment of uterocutaneous fistulae.
authors.affiliation: Department of Obstetrics and Gynecology, the American Hospital of Istanbul, Istanbul, Turkish Republic.
authors.forename: Ayse
authors.initials: A
authors.lastname: Seyhan
authors.forename: Baris
authors.initials: B
authors.lastname: Ata
authors.forename: Bilhan
authors.initials: B
authors.lastname: Sidal
authors.forename: Bulent
authors.initials: B
authors.lastname: Urman
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002585:Cesarean Section / Q000009:adverse effects; D017577:Cutaneous Fistula / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use*; D014591:Uterine Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide